9,913 Shares in Amdocs Limited $DOX Purchased by SEB Asset Management AB

SEB Asset Management AB purchased a new stake in Amdocs Limited (NASDAQ:DOXFree Report) in the first quarter, Holdings Channel.com reports. The firm purchased 9,913 shares of the technology company’s stock, valued at approximately $647,000.

Other hedge funds have also recently bought and sold shares of the company. Pzena Investment Management LLC increased its holdings in Amdocs by 5.4% during the 1st quarter. Pzena Investment Management LLC now owns 12,681,089 shares of the technology company’s stock worth $827,568,000 after purchasing an additional 644,074 shares during the last quarter. LSV Asset Management boosted its stake in shares of Amdocs by 0.8% during the 4th quarter. LSV Asset Management now owns 3,678,532 shares of the technology company’s stock valued at $296,159,000 after buying an additional 29,829 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its stake in shares of Amdocs by 1.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,165,988 shares of the technology company’s stock valued at $253,786,000 after buying an additional 54,676 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Amdocs by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,151,532 shares of the technology company’s stock worth $258,583,000 after buying an additional 91,900 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of Amdocs by 24.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,892,761 shares of the technology company’s stock worth $232,903,000 after buying an additional 560,380 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Price Performance

Shares of DOX opened at $52.10 on Friday. Amdocs Limited has a 52 week low of $49.74 and a 52 week high of $90.29. The company has a current ratio of 0.98, a quick ratio of 0.98 and a debt-to-equity ratio of 0.23. The firm has a market cap of $5.62 billion, a price-to-earnings ratio of 10.42, a PEG ratio of 0.88 and a beta of 0.41. The stock has a 50 day moving average of $55.64 and a 200-day moving average of $65.19.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings results on Thursday, May 14th. The technology company reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.77 by $0.01. Amdocs had a return on equity of 19.77% and a net margin of 11.81%.The business had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same period in the prior year, the company posted $1.78 EPS. The business’s revenue was up 3.9% compared to the same quarter last year. As a group, analysts forecast that Amdocs Limited will post 6.56 EPS for the current year.

Amdocs Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.569 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.28 annualized dividend and a yield of 4.4%. Amdocs’s payout ratio is presently 45.60%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Wall Street Zen cut shares of Amdocs from a “buy” rating to a “hold” rating in a report on Sunday, July 5th. Cfra downgraded shares of Amdocs to a “sell” rating in a research note on Thursday, May 14th. Stifel Nicolaus decreased their price objective on shares of Amdocs from $88.00 to $71.00 and set a “buy” rating for the company in a report on Thursday, May 14th. KeyCorp started coverage on shares of Amdocs in a research report on Monday, June 29th. They issued a “sector weight” rating for the company. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Amdocs in a research note on Friday, May 8th. Three analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Amdocs presently has an average rating of “Hold” and a consensus price target of $86.67.

Get Our Latest Stock Analysis on DOX

Amdocs Profile

(Free Report)

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.

Further Reading

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.